Bob Mitchell

Bayer ( BAYRY ) along with partner, Regeneron Pharmaceuticals Inc. ( REGN ) recently announced positive 52 week data from …read more

GlaxoSmithKline ( GSK ) recently announced that the decision on the approval of its diabetes candidate, albiglutide, from the U.S. …read more

We have retained our Neutral recommendation on H&R Block Inc . ( HRB ) as it reported a mixed fourth …read more

Leading passenger airline JetBlue Airways Corporation ( JBLU ) will offer lie flat seats on flights between New York and …read more

On Aug 3, Zacks Investment Research upgraded Provident Financial Holdings, Inc. ( PROV ) to a Zacks Rank #1 (Strong …read more

Sun Life Financial Inc. ( SLF ) has announced that it has successfully concluded the sale of some its U.S. …read more

Astellas Pharma, Inc. ( ALPMY ) and FibroGen Inc., a privately held biotechnology company, recently commenced a phase II study …read more

Bayer ‘s ( BAYRY ) HealthCare segment recently entered into an oncology collaboration and licence agreement with Compugen Ltd. ( …read more

Pacira Pharmaceuticals, Inc. ( PCRX ) recently announced disappointing data from its second pivotal phase III study on Exparel. The …read more

In a continuous effort to grow its mobile money transfer service facility Western Union Co. ( WU ) has entered …read more